Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.

about

Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function.An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease.

P2860

Q48033580-F88B1C75-247C-48DF-8268-5ED6EA206EE9 Q50888630-38B6935C-D18F-441E-BDCF-B707DF972BFC

P2860

Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.

Item

http://www.wikidata.org/entity/Q38683067

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Natural Nuclear Factor Kappa B ...... or Inflammatory Bowel Disease.

@en

type

Item

label

Natural Nuclear Factor Kappa B ...... or Inflammatory Bowel Disease.

@en

prefLabel

Natural Nuclear Factor Kappa B ...... or Inflammatory Bowel Disease.

@en

P1476

Natural Nuclear Factor Kappa B ...... or Inflammatory Bowel Disease.

@en

P2860

Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.

Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B

Mesalamine in the treatment and maintenance of remission of ulcerative colitis

Next-Generation Therapeutics for IBD

The burden of inflammatory bowel disease in Europe

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

Missing pieces in the NF-kappaB puzzle

Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NFκB pathway.

Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials.

P304

719-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000000655

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Murtaza M Tambuwala

P577

2015-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26717321

http://www.w3.org/2001/XMLSchema#string

Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.

about

P2860

P2860

Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698